Cargando…
Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery
Gene therapy is a critical tool for the treatment of monogenic retinal diseases. However, the limited vector capacity of the current benchmark delivery strategy, adeno-associated virus (AAV), makes development of larger capacity alternatives, such as compacted DNA nanoparticles (NPs), critical. Here...
Autores principales: | Han, Zongchao, Conley, Shannon M., Makkia, Rasha, Guo, Junjing, Cooper, Mark J., Naash, Muna I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525534/ https://www.ncbi.nlm.nih.gov/pubmed/23272225 http://dx.doi.org/10.1371/journal.pone.0052189 |
Ejemplares similares
-
DNA nanoparticles are safe and nontoxic in non-human primate eyes
por: Kelley, Ryan A, et al.
Publicado: (2018) -
Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina
por: Ding, Xi-Qin, et al.
Publicado: (2009) -
Efficient Non-Viral Ocular Gene Transfer with Compacted DNA Nanoparticles
por: Farjo, Rafal, et al.
Publicado: (2006) -
A Partial Structural and Functional Rescue of a Retinitis Pigmentosa Model with Compacted DNA Nanoparticles
por: Cai, Xue, et al.
Publicado: (2009) -
Overexpression of Retinal Degeneration Slow (RDS) Protein Adversely Affects Rods in the rd7 Model of Enhanced S-Cone Syndrome
por: Chakraborty, Dibyendu, et al.
Publicado: (2013)